WHAT IS SEMAGLUTIDE?
Semaglutide is approved for chronic weight management in qualifying patients. Semaglutide is a selective glucagon-like peptide-1 (GLP-1) receptor agonist that acts in the areas of the brain involved in regulation of appetite and caloric intake and slows gastric emptying. Only a single, small injection of Semaglutide is required at home each week. Contact Affinity today to learn more!
WHAT OUR PATIENTS SAY
MEET OUR MEDICAL DIRECTOR, DR. KOEHLER
Dr. Michael Koehler is Affinity's Medical Director and a board-certified emergency medicine physician. A native Texan, Dr. Koehler received his Doctor of Medicine from the University of Texas in San Antonio after obtaining his Bachelor of Science degree from the University of Notre Dame. Dr. Koehler completed his emergency medicine residency at Carolinas Medical Center in Charlotte where he also served as chief resident. Following residency, Dr. Koehler provides quality emergency department care to thousands of patients in addition to supervising and educating medical students, residents, physician assistants, and nurse practitioners.
In his spare time, Dr. Koehler enjoys weightlifting, watching football, and spending time with his wife and two sons.
FREQUENTLY ASKED QUESTIONS
Some patients report losing a pound per week or more in their first months of treatment. Results vary based on dosage, starting weight, activity levels and other factors.
Located at 1901 S Meyers Rd, Suite 130, Oakbrook Terrace, IL 60181